Physician Investigator (Cl) Psychiatry, Mass General Research Institute

Associate Professor of Psychiatry Harvard Medical School

Psychiatrist Psychiatry, Massachusetts General Hospital

MD King George Med College 1988

adolescent psychiatry; antimanic agents; bipolar disorder; carbamazepine; child development disorders pervasive; conduct disorder; diagnostic and statistical manual of mental disorders; dibenzothiazepines; isoxazoles; memantine; obsessive-compulsive disorder; social behavior disorders

Dr. Gagan Joshi is a clinical investigator in the Pediatric Psychopharmacology Clinical and Research Programs at the Massachusetts General Hospital, and Instructor in Psychiatry at Harvard Medical School.

Dr. Joshi trained in General Psychiatry at the Hospital of the University of Pennsylvania and subsequently completed his Fellowship training in Child and Adolescent Psychiatry at the combined program of Massachusetts General Hospital and McLean Hospital, Harvard Medical School. He received training in cognitive-behavioral therapy at the Beck Institute for Cognitive Therapy and trained in psychodynamic psychotherapy at the Philadelphia Psychoanalytic Institute & Society.

Dr. Joshi has been the recipient of the prestigious Ethel Dupont Warren Fellowship Award through the Department of Psychiatry at Harvard Medical School. He is also the recipient of the XXVth Collegium Internationale Neuro-Psychopharmalogicum Congress Young Investigators Award, and the American Academy of Child and Adolescent Psychiatry Pilot Research Award. Dr. Joshi’s clinical and research interest is in Pediatric Bipolar Disorder and Pervasive Developmental Disorders with particular focus on the often-neglected comorbid conditions associated with these disorders. Besides coordinating research projects in pediatric bipolar disorder, Dr. Joshi is facilitating the expansion of research in Pervasive Developmental Disorders and related comorbidities in the Pediatric Psychopharmacology Program at MGH. He has developed specific research projects examining the overlap of bipolar disorder with obsessive-compulsive disorder in children and adolescents. His research - addressing the treatment of obsessive-compulsive disorder symptoms in youth with bipolar disorder - is supported by grants from the Ethel Dupont Warren Fellowship and Pilot Research Award.